Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

The Citizens JMP Life Sciences Conference Fireside Chat: Tuesday, May 14, 2024 at 11:00 am ET Location: New York, NY

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

H.C. Wainwright 2nd Annual BioConnect Investor ConferenceFireside Chat: Monday, May 20, 2024 at 10:30 am ET Location: New York, NY

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076[email protected]

You May Also Be Interested In

• QuoMarkets Introduces Weekend XAUUSD Trading as Demand for Continuous Market Access Grows
• CHiQ Wins AI Home Ecosystem Brand Award, Exploring New Smart Living Experiences Through AI Innovation
• TORRAS Introduces Ostand Q3 Air Pro as Its Second Flagship Case for iPhone 18